<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Cervical intraepithelial neoplasia: Ablative therapies
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Cervical intraepithelial neoplasia: Ablative therapies
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Cervical intraepithelial neoplasia: Ablative therapies
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Nicholas P Taylor, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Barbara Goff, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Alana Chakrabarti, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Feb 07, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cervical intraepithelial neoplasia (CIN) is a premalignant cervical disease that can be treated with either excisional (ie, conization) or ablative therapy.
        </p>
        <p>
         Ablative techniques include cryotherapy, CO
         <sub>
          2
         </sub>
         laser, thermal ablation (cold coagulation), and diathermy. Unlike with excision, ablation provides no pathologic specimen as the cervical tissue is destroyed. Therefore, these procedures are purely therapeutic and not of diagnostic value. They are appropriate only for select patients with previously well-characterized lesions histologically and colposcopically in whom invasive cancer has been excluded.
        </p>
        <p>
         The ablative procedures for the treatment of CIN are reviewed here. The management of CIN, indications for ablation and excision, how to choose between the treatment options, and the procedures for excision are discussed elsewhere.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3215.html" rel="external">
          "Cervical intraepithelial neoplasia: Management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/89208.html" rel="external">
          "Cervical intraepithelial neoplasia: Choosing excision versus ablation, and prognosis and follow-up after treatment"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3255.html" rel="external">
          "Cervical intraepithelial neoplasia: Diagnostic excisional procedures"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H516203140">
         <span class="h1">
          CHOOSING AN ABLATION TECHNIQUE
         </span>
         <span class="headingEndMark">
          —
         </span>
         In our practice, we prefer cryotherapy to laser ablation or thermal ablation. However, ablative techniques have a relatively low risk of side effects and, until there are more informative comparative efficacy data, choice of ablative method may be dictated by other factors (eg, local resources).
        </p>
        <p>
         For patients with CIN 1, there is some evidence that cryotherapy is more effective than laser ablation:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a subgroup analysis of a meta-analysis of randomized trials, patients with CIN 1 treated with laser ablation compared with cryotherapy had a higher risk of residual disease (odds ratio [OR] 3.3, 95% CI 1.1-10.1) [
         <a href="#rid1">
          1
         </a>
         ]. The strength of this conclusion is attenuated by the use of an unplanned subgroup analysis and by the methodologic flaws in the included trials.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a randomized trial including 500 patients eligible for ablative treatment after visual inspection with
         <a class="drug drug_general" data-topicid="9277" href="/z/d/drug information/9277.html" rel="external">
          acetic acid
         </a>
         (VIA), those treated with cryotherapy or thermal ablation had similar proportions of HPV clearance six months after treatment, but the study was not powered to detect such difference [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The efficacy of cryotherapy, CO
         <sub>
          2
         </sub>
         laser, and thermal ablation is also being evaluated in a noninferiority randomized trial including 1152 patients with CIN 2 or greater; this trial is ongoing and efficacy data have not yet been published [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         While cryotherapy is more commonly used in the United States and more cost-effective in some settings [
         <a href="#rid4">
          4
         </a>
         ], thermal ablation may have advantages in some resource-limited countries as it is available as a portable, lightweight, and battery-operated device. Both cryotherapy and thermal ablation are relatively simple, inexpensive office procedures. By contrast, laser equipment is costly, and a laser procedure may require general anesthesia in an inpatient setting [
         <a href="#rid5">
          5
         </a>
         ]. A disadvantage of cryotherapy is that a malodorous vaginal discharge is a common side effect and vasomotor symptoms may occur during the procedure [
         <a href="#rid1">
          1
         </a>
         ]; however, these effects are easily managed. (See
         <a class="local">
          'Adverse effects'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          GENERAL PROCEDURAL ISSUES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cryotherapy and thermal ablation are office procedures. Both CO
         <sub>
          2
         </sub>
         laser ablation and electrocoagulation diathermy may be performed in an office setting, but as they are more painful to patients, general anesthesia in an operating room may be necessary [
         <a href="#rid5">
          5,6
         </a>
         ]. Routine preoperative laboratory tests, cultures, and antibiotic prophylaxis are not required.
        </p>
        <p>
         We pretreat with an oral nonsteroidal anti-inflammatory drug (NSAID) to minimize procedure-related cramping (eg,
         <a class="drug drug_general" data-topicid="8547" href="/z/d/drug information/8547.html" rel="external">
          ibuprofen
         </a>
         600 mg). A local anesthetic should be provided. Options include injection into the cervical stroma or as a paracervical block; we prefer a stromal block. In one decision analysis, stromal block was the most cost-effective method to avert the pain and cramping during cryosurgery (in patients who have taken an NSAID before the procedure) [
         <a href="#rid7">
          7
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5404.html" rel="external">
          "Pudendal and paracervical block", section on 'Gynecologic procedures'
         </a>
         .)
        </p>
        <p>
         For all techniques, the cervix is stained with Lugol iodine (a solution of elemental iodine and potassium iodide in water) to delineate the lesion to be ablated. If Lugol is not available, 3 to 5%
         <a class="drug drug_general" data-topicid="9277" href="/z/d/drug information/9277.html" rel="external">
          acetic acid
         </a>
         can be used.
        </p>
        <p>
         Most patients will report minor cramping, similar to menstrual cramps, during and after the procedure. Vasomotor symptoms (eg, light-headedness) may occur, and are more common during cryotherapy than during laser ablation [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1047026920">
         <span class="h1">
          HEALTH CARE WORKERS AT RISK FOR OCCUPATIONAL EXPOSURE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Smoke generated from excisional and ablative procedures for CIN can expose health care workers to human papillomavirus (HPV) and increase the risk of developing HPV infection and HPV-associated oropharyngeal disease, such as papillomatosis and cancer [
         <a href="#rid9">
          9
         </a>
         ]. In addition to personal protective equipment (eg, N-95 masks) and smoke evacuation systems, we agree with guidance from the American Society for Colposcopy and Cervical Pathology and others that all health care workers with this exposure (eg, physicians, nurses, operating room staff) should receive the HPV vaccine, if not already vaccinated [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
         This is discussed in more detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/3255.html" rel="external">
          "Cervical intraepithelial neoplasia: Diagnostic excisional procedures", section on 'Health care workers at risk for occupational exposure'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8325.html" rel="external">
          "Human papillomavirus vaccination", section on 'Health care workers at risk for occupational exposure'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          ABLATIVE TECHNIQUES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cryotherapy and laser ablation are the most commonly used methods for cervical ablation. Cold coagulation and diathermy are used infrequently in the United States.
        </p>
        <p>
         CIN can extend into glandular crypts, thus, the depth of cervical ablation should be at least 4.8 mm for all techniques. This will adequately treat greater than 99 percent of lesions [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Cryotherapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cryotherapy uses a refrigerant gas (carbon dioxide or
         <a class="drug drug_general" data-topicid="10086" href="/z/d/drug information/10086.html" rel="external">
          nitrous oxide
         </a>
         ) to cool the ectocervix with a metal cryoprobe. The ectocervix must be cooled to -20°C to cause crystallization of intracellular water and destroy the lesion [
         <a href="#rid12">
          12
         </a>
         ]. This can be achieved by forming an ice ball in the cervical tissue that is at least 5 mm from the tip of the probe. Cryotherapy should not be used for dysplasia that encompasses more than 75 percent of the cervix or with lesions that are larger than the selected cryoprobe [
         <a href="#rid13">
          13
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/89208.html" rel="external">
          "Cervical intraepithelial neoplasia: Choosing excision versus ablation, and prognosis and follow-up after treatment", section on 'Factors to consider in choosing excision versus ablation'
         </a>
         .)
        </p>
        <p>
         Cryoprobes are either flat or cone shaped and vary in diameter (19 or 25 mm). It is not clear whether cryoprobe shape influences treatment efficacy [
         <a href="#rid14">
          14,15
         </a>
         ]. Selection of the appropriate cryoprobe is controversial. In one study (n = 64), cryotherapy was performed on patients prior to hysterectomy, and postoperative histology revealed that adequate tissue destruction (in this study, defined as 4 mm depth and ≤15 mm width) was significantly more likely after use of the large cone-shaped probe (25 mm diameter) than the small flat probe (19 mm diameter; 80 versus 58 percent); results for the other probes (small cone-shaped and large flat) did not differ significantly from the others (67 and 72 percent) [
         <a href="#rid14">
          14
         </a>
         ]. However, in a randomized trial (n = 117) patients with CIN were assigned to cryotherapy with either a cone-shaped or flat probe (selection of large or small probe was made according to size of cervix); rates of disease found at follow-up colposcopy were similar (77 and 76 percent) [
         <a href="#rid15">
          15
         </a>
         ].
        </p>
        <p>
         The type of refrigerant gas may also influence outcome. Tissue crystallization induced by
         <a class="drug drug_general" data-topicid="10086" href="/z/d/drug information/10086.html" rel="external">
          nitrous oxide
         </a>
         appears to penetrate deeper into the cervical stroma than CO
         <sub>
          2
         </sub>
         [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Technique
         </strong>
         – Select the appropriate probe and apply a water-soluble lubricant to the probe tip to allow adequate transfer of thermal energy between the probe and the cervical tissue. A note of caution, if the cryoprobe makes contact with the speculum, vaginal tissue in contact with the speculum will also be ablated. An insulated speculum may be used, but is not required.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Activate the cryotherapy unit and, when the optimal freezing temperature is achieved (-65 to -85°C), administer a three-minute freeze and then turn the unit off to allow the cervix to thaw for five minutes. The probe will then fall free of the cervix and a white "frost" area will be visible. Removing the probe, rather than allowing it to fall off, will cause pain and bleeding. Continue to allow the cervix to defrost and become pink.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Perform a second freeze and again allow the cervix to defrost [
         <a href="#rid17">
          17
         </a>
         ]. In a large meta-analysis of randomized trials, using two freeze/thaw cycles was more effective than one cycle (residual disease rates at 27-month follow-up were 6 versus 16 percent) [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          CO2 laser
         </span>
         <span class="headingEndMark">
          —
         </span>
         Laser surgery should only be performed by clinicians with specialized training. The laser is directed at the cervical lesion under colposcopic guidance. Water in the tissue absorbs the laser energy, which destroys the tissue by vaporization. To be effective, the lesion is typically ablated to a depth of 5 mm on the ectocervix and 8 to 9 mm around the endocervix.
        </p>
        <p>
         Laser ablation of visible lesions is discussed here; a full discussion of laser conization (ie, the transformation zone is excised using a laser) and principles of laser therapy can be found separately. (See
         <a class="medical medical_review" href="/z/d/html/2883.html" rel="external">
          "Basic principles of medical lasers"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3255.html" rel="external">
          "Cervical intraepithelial neoplasia: Diagnostic excisional procedures", section on 'Laser conization'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Technique
         </strong>
         – Protective eyewear is necessary for any personnel in the procedure room. To avoid inadvertent damage to the surrounding areas from a reflected or misdirected laser beam, use a coated or brushed (ie, nonconductive) speculum and drape the patient's perineum and thighs with wet towels. Avoid paper drapes, as they are flammable.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Visualize the cervix using a colposcope. Using a CO
         <sub>
          2
         </sub>
         laser with a power density of 600 to 1200 watts/cm
         <sup>
          2
         </sup>
         is adequate for vaporization. For example, with a spot size of 2 mm, setting the laser to 35 watts will produce a power density of 875 watts/cm
         <sup>
          2
         </sup>
         . In general, obtaining hemostasis requires a spot size of 5 mm or greater.
        </p>
        <p>
        </p>
        <p>
         Technique varies among surgeons, and there are no data comparing these methods. Some experts advocate using the laser in ultrapulse mode to decrease thermal damage to the surrounding cervical stroma. Also, some experts advise lasering the ectocervix with a defocused beam to provide a several-millimeter margin around the area previously ablated (ie, "brush" lasering).
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Thermal ablation (cold coagulation)
         </span>
         <span class="headingEndMark">
          —
         </span>
         Thermal ablation and cold coagulation are the same technique; despite the term "cold" coagulation, this method uses heat to ablate the cervical stroma. The term "cold" coagulation is used because lower temperatures are used compared with electrocoagulation diathermy ablation (see
         <a class="local">
          'Diathermy'
         </a>
         below). Similar to cryotherapy, a probe (thermosound) is used to conduct heat to the cervix. Probe temperatures vary from 50 to 120°C. Depth of penetration into the cervical stroma depends on the temperature of the probe and duration of probe application.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Technique
         </strong>
         – Cold coagulation is not commonly used, and a standard technique has not been established. In the largest single-institution experience, a temperature of 100°C was applied for 20 seconds with overlapping treatment fields for a total treatment time of 40 to 100 seconds [
         <a href="#rid18">
          18
         </a>
         ]. Newer thermal ablation units (eg, hand-held, rechargeable) can reach treatment temperature in six seconds; treatment time is similar at approximately 45 seconds [
         <a href="#rid19">
          19
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Diathermy
         </span>
         <span class="headingEndMark">
          —
         </span>
         The term diathermy means "electrically induced heat." This technique uses a needle that is attached to an electrosurgical generator (cautery device) to destroy cervical tissue.
        </p>
        <p>
         Diathermy is primarily performed as an inpatient procedure requiring general anesthesia [
         <a href="#rid20">
          20-22
         </a>
         ], but it can be used in the outpatient setting [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Technique
         </strong>
         – The diathermy needle is passed into and out of the cervix multiple times to ablate the transformation zone; a spatula can be used to remove desiccated tissue. A setting of 30 to 35 watts has been described, but there does not appear to be a consensus on the optimal current [
         <a href="#rid20">
          20
         </a>
         ]. The speculum should not touch the diathermy needle.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h1">
          OUTCOME
         </span>
         <span class="headingEndMark">
          —
         </span>
         Overall, all types of ablative therapy for CIN appear to be effective, with low rates of disease persistence and recurrence (generally &lt;10 percent) at seven or more years after treatment [
         <a href="#rid21">
          21,23-30
         </a>
         ].
        </p>
        <p>
         Despite the high success rates with ablative modalities (particularly CO
         <sub>
          2
         </sub>
         laser and cryotherapy), CIN 2 or 3 or cancer can be missed without an excisional biopsy.
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h1">
          ADVERSE EFFECTS AND COMPLICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Overall, complication rates after ablative therapy are low, approximately 1 to 2 percent [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Adverse effects
         </span>
         <span class="headingEndMark">
          —
         </span>
         Adverse effects are relatively uncommon and data regarding discharge, bleeding, and pain are conflicting.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Discharge
         </strong>
         – In one meta-analysis, patients were less likely to experience vaginal discharge after laser ablation than cryotherapy (odds ratio [OR] 0.23, 95% CI 0.15-0.35; two trials) [
         <a href="#rid8">
          8
         </a>
         ]. However, in the ongoing randomized noninferiority trial discussed above (see
         <a class="local">
          'Choosing an ablation technique'
         </a>
         above), patients treated with CO
         <sub>
          2
         </sub>
         laser experienced a longer duration of watery discharge [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Watery vaginal discharge can continue for several weeks after treatment. When patients find the discharge bothersome, we remove the necrotic tissue from the cervix using ring forceps.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Bleeding
         </strong>
         – In the above meta-analysis, patients treated with laser ablation compared with cryotherapy were more likely to experience severe bleeding (OR 7.45, 95% CI 1.68-33) [
         <a href="#rid8">
          8
         </a>
         ]. By contrast, in interim data from the ongoing randomized noninferiority trial discussed above (see
         <a class="local">
          'Choosing an ablation technique'
         </a>
         above), thermal ablation was associated with more frequent bleeding (thermal ablation: 30 percent, cryotherapy: 20 percent, CO
         <sub>
          2
         </sub>
         laser: 19 percent) [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Patients with posttreatment bleeding are evaluated with a speculum examination. Bleeding is usually minimal and will resolve with conservative measures in the office, such as application of
         <a class="drug drug_general" data-topicid="9888" href="/z/d/drug information/9888.html" rel="external">
          silver nitrate
         </a>
         or
         <a class="drug drug_general" data-topicid="83319" href="/z/d/drug information/83319.html" rel="external">
          ferric subsulfate
         </a>
         (Monsel solution). It is rare to encounter bleeding that requires suturing or packing.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Infection
         </strong>
         – Pelvic infection after ablation is infrequent but may be increased in patients with other risk factors for pelvic inflammatory disease (PID). For example, in one series of 67 adolescents treated with cryotherapy, 9 percent developed PID [
         <a href="#rid31">
          31
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pain
         </strong>
         – In the above meta-analysis, laser ablation compared with cryotherapy was associated with a higher incidence of severe peri‐operative severe pain (OR 2.38, 95% CI 0.9-6.28) [
         <a href="#rid8">
          8
         </a>
         ]. By contrast, in a randomized trial including 500 patients eligible for ablative treatment after visual inspection with
         <a class="drug drug_general" data-topicid="9277" href="/z/d/drug information/9277.html" rel="external">
          acetic acid
         </a>
         (VIA) discussed above (see
         <a class="local">
          'Choosing an ablation technique'
         </a>
         above), those treated with thermal ablation compared with cryotherapy had similar pain scores immediately, and at two weeks, after treatment; the majority of patients rated their pain at a one to three on a nine-point scale [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In interim data from the ongoing randomized noninferiority trial discussed above (see
         <a class="local">
          'Choosing an ablation technique'
         </a>
         above), thermal ablation was associated with higher pain levels during treatment (interquartile range [IQR]: 4) compared with laser (2) and cryotherapy (2) [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h2">
          Late complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Possible late complications are cervical stenosis or obstetric complications.
        </p>
        <p>
         Cervical stenosis appears to be rare after cryotherapy or laser ablation; however, there are few data regarding this issue [
         <a href="#rid31">
          31,32
         </a>
         ]. In the largest series of cryotherapy or laser ablation, the risk of stenosis was 1 percent or less [
         <a href="#rid32">
          32,33
         </a>
         ]. Although a randomized trial found no significant difference in the incidence of cervical stenosis between the two methods, there was insufficient statistical power to detect a difference in this rare complication [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p>
         There is some evidence that the risk of cervical stenosis following cervical ablation is increased for patients with a history of in-utero exposure to diethylstilbestrol [
         <a href="#rid34">
          34,35
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5427.html" rel="external">
          "Outcome and follow-up of diethylstilbestrol (DES) exposed individuals"
         </a>
         .)
        </p>
        <p>
         The risk of obstetric complications (eg, preterm delivery) appears to be lower in patients treated with ablative rather than excisional methods. A full discussion of the association of treatment of CIN with obstetric complications can be found separately. (See
         <a class="medical medical_review" href="/z/d/html/3210.html" rel="external">
          "Reproductive effects of cervical excisional and ablative procedures"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h1">
          FOLLOW-UP
         </span>
         <span class="headingEndMark">
          —
         </span>
         We see patients at 10 to 14 days after the procedure and treat any short-term complications. Appropriate follow-up after ablative treatment for CIN is especially critical, as no pathologic diagnosis is obtained at the time of treatment and some patients will go on to develop cancer [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p>
         After laser ablation, the squamocolumnar junction usually returns to its pretreatment location and can be visualized [
         <a href="#rid8">
          8
         </a>
         ]. However, following cryotherapy, the squamocolumnar junction may recede into the cervical canal, making subsequent colposcopy difficult. Radial scar lines may also be seen with subsequent colposcopies, and are of no clinical significance.
        </p>
        <p>
         Recommendations for follow-up after treatment for CIN are discussed in detail separately elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/3215.html" rel="external">
          "Cervical intraepithelial neoplasia: Management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H161201684">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/117738.html" rel="external">
          "Society guideline links: Cervical cancer screening, prevention, and management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H21">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/8391.html" rel="external">
          "Patient education: Follow-up of low-grade abnormal Pap tests (Beyond the Basics)"
         </a>
         and
         <a class="medical medical_patient" href="/z/d/html/8417.html" rel="external">
          "Patient education: Follow-up of high-grade or glandular cell abnormal Pap tests (Beyond the Basics)"
         </a>
         and
         <a class="medical medical_patient" href="/z/d/html/8407.html" rel="external">
          "Patient education: Management of a cervical biopsy with precancerous cells (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical significance
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         While ablative therapy is an effective treatment of cervical intraepithelial neoplasia (CIN) for a select group of patients with previously well-characterized lesions histologically and colposcopically in whom invasive cancer has been excluded, most patients with CIN 2 or 3 will undergo a diagnostic excisional procedure. (See
         <a class="local">
          'Introduction'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/89208.html" rel="external">
          "Cervical intraepithelial neoplasia: Choosing excision versus ablation, and prognosis and follow-up after treatment", section on 'Factors to consider in choosing excision versus ablation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3255.html" rel="external">
          "Cervical intraepithelial neoplasia: Diagnostic excisional procedures"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Ablative modalities are solely for treatment, while excisional therapy provides diagnostic information as well as therapeutic benefit. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Techniques
         </strong>
         – The most commonly used techniques for cervical ablation are cryotherapy and laser ablation; thermal ablation and electrocoagulation diathermy are used infrequently in the United States. Most procedures can be performed in an office setting. (See
         <a class="local">
          'Ablative techniques'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          How to choose
         </strong>
         – For patients with CIN 1 who are candidates for ablative therapy, we suggest cryotherapy rather than laser or thermal ablation (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). For patients with CIN 1, there is some evidence that cryotherapy is more effective than laser ablation. However, ablative techniques have a relatively low risk of side effects and, until there is more informative comparative efficacy data, choice of ablative method may be dictated by local resources. (See
         <a class="local">
          'Choosing an ablation technique'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cryotherapy
         </strong>
         – For patients undergoing cryotherapy, we recommend two freeze/thaw cycles rather than one cycle (
         <a class="grade" href="https:///uptodate/show/grade_1" rel="external">
          Grade 1A
         </a>
         ). (See
         <a class="local">
          'Cryotherapy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Outcome
         </strong>
         – Overall, all types of ablative therapy for CIN appear to be effective, with low rates of disease persistence and recurrence (generally &lt;10 percent) at seven or more years after treatment. (See
         <a class="local">
          'Outcome'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Adverse effects and complications
         </strong>
         – Incidences of adverse effects and complications after ablative therapy are low, approximately 1 to 2 percent. (See
         <a class="local">
          'Adverse effects and complications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Follow-up
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         We see patients at 10 to 14 days after the procedure. Appropriate follow-up after ablative treatment for CIN is especially critical, as no pathologic diagnosis is obtained at the time of treatment and some patients will go on to develop cancer. (See
         <a class="local">
          'Follow-up'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Recommendations for follow-up after treatment for CIN are discussed in detail separately elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/3215.html" rel="external">
          "Cervical intraepithelial neoplasia: Management"
         </a>
         .)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Martin-Hirsch PP, Paraskevaidis E, Bryant A, et al. Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst Rev 2010; :CD001318.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pinder LF, Parham GP, Basu P, et al. Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: pilot phase of a randomised controlled trial. Lancet Oncol 2020; 21:175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Soler M, Alfaro K, Masch RJ, et al. Safety and Acceptability of Three Ablation Treatments for High-Grade Cervical Precancer: Early Data From a Randomized Noninferiority Clinical Trial. JCO Glob Oncol 2022; 8:e2200112.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kleinberg MJ, Straughn JM Jr, Stringer JS, Partridge EE. A cost-effectiveness analysis of management strategies for cervical intraepithelial neoplasia grades 2 and 3. Am J Obstet Gynecol 2003; 188:1186.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johnson N, Crompton AC. Who finds cervical laser therapy painful? Gynecol Oncol 1994; 52:44.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schuurmans SN, Ohlke ID, Carmichael JA. Treatment of cervical intraepithelial neoplasia with electrocautery: report of 426 cases. Am J Obstet Gynecol 1984; 148:544.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harper DM, Cobb JL. Is it cost-effective to use a mucosal or paracervical block to relieve the pain and cramping from cryosurgery? A decision model. J Fam Pract 1999; 48:285.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martin-Hirsch PL, Paraskevaidis E, Kitchener H. Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst Rev 2000; :CD001318.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harrison R, Huh W. Occupational Exposure to Human Papillomavirus and Vaccination for Health Care Workers. Obstet Gynecol 2020; 136:663.
          </a>
         </li>
         <li class="breakAll">
          https://www.asccp.org/Assets/d3abdb05-25c5-4e58-9cec-05c11fb2b920/637177876310030000/hpv-vaccine-member-announcment-02-19-20-pdf (Accessed on September 28, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abdul-Karim FW, Fu YS, Reagan JW, Wentz WB. Morphometric study of intraepithelial neoplasia of the uterine cervix. Obstet Gynecol 1982; 60:210.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hatch KD. Cryotherapy. Baillieres Clin Obstet Gynaecol 1995; 9:133.
          </a>
         </li>
         <li class="breakAll">
          WHO Guidelines: Use of Cryotherapy for Cervical Intraepithelial Neoplasia, World Health Organization.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boonstra H, Koudstaal J, Oosterhuis JW, et al. Analysis of cryolesions in the uterine cervix: application techniques, extension, and failures. Obstet Gynecol 1990; 75:232.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stienstra KA, Brewer BE, Franklin LA. A comparison of flat and shallow conical tips for cervical cryotherapy. J Am Board Fam Pract 1999; 12:360.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mariategui J, Santos C, Taxa L, et al. Comparison of depth of necrosis achieved by CO2- and N2O-cryotherapy. Int J Gynaecol Obstet 2008; 100:24.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Creasman WT, Weed JC Jr, Curry SL, et al. Efficacy of cryosurgical treatment of severe cervical intraepithelial neoplasia. Obstet Gynecol 1973; 41:501.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duncan ID. Cold coagulation. Baillieres Clin Obstet Gynaecol 1995; 9:145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duan L, Du H, Belinson JL, et al. Thermocoagulation versus cryotherapy for the treatment of cervical precancers. J Obstet Gynaecol Res 2021; 47:279.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Woodman CB, Jordan JA, Mylotte MJ, et al. The management of cervical intraepithelial neoplasia by coagulation electrodiathermy. Br J Obstet Gynaecol 1985; 92:751.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chanen W, Rome RM. Electrocoagulation diathermy for cervical dysplasia and carcinoma in situ: a 15-year survey. Obstet Gynecol 1983; 61:673.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Giles JA, Walker PG, Chalk PA. Treatment of cervical intraepithelial neoplasia (CIN) by radical electrocoagulation diathermy: 5 years' experience. Br J Obstet Gynaecol 1987; 94:1089.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitchell MF, Tortolero-Luna G, Cook E, et al. A randomized clinical trial of cryotherapy, laser vaporization, and loop electrosurgical excision for treatment of squamous intraepithelial lesions of the cervix. Obstet Gynecol 1998; 92:737.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kwikkel HJ, Helmerhorst TJ, Bezemer PD, et al. Laser or cryotherapy for cervical intraepithelial neoplasia: a randomized study to compare efficacy and side effects. Gynecol Oncol 1985; 22:23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Townsend DE, Richart RM. Cryotherapy and carbon dioxide laser management of cervical intraepithelial neoplasia: a controlled comparison. Obstet Gynecol 1983; 61:75.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ferenczy A. Comparison of cryo- and carbon dioxide laser therapy for cervical intraepithelial neoplasia. Obstet Gynecol 1985; 66:793.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chew GK, Jandial L, Paraskevaidis E, Kitchener HC. Pattern of CIN recurrence following laser ablation treatment: long-term follow-up. Int J Gynecol Cancer 1999; 9:487.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Draeby-Kristiansen J, Garsaae M, Bruun M, Hansen K. Ten years after cryosurgical treatment of cervical intraepithelial neoplasia. Am J Obstet Gynecol 1991; 165:43.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gordon HK, Duncan ID. Effective destruction of cervical intraepithelial neoplasia (CIN) 3 at 100 degrees C using the Semm cold coagulator: 14 years experience. Br J Obstet Gynaecol 1991; 98:14.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cirisano FD. Management of pre-invasive disease of the cervix. Semin Surg Oncol 1999; 16:222.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hillard PA, Biro FM, Wildey L. Complications of cervical cryotherapy in adolescents. J Reprod Med 1991; 36:711.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Loobuyck HA, Duncan ID. Destruction of CIN 1 and 2 with the Semm cold coagulator: 13 years' experience with a see-and-treat policy. Br J Obstet Gynaecol 1993; 100:465.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baggish MS, Dorsey JH, Adelson M. A ten-year experience treating cervical intraepithelial neoplasia with the CO2 laser. Am J Obstet Gynecol 1989; 161:60.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schmidt G, Fowler WC Jr. Cervical stenosis following minor gynecologic procedures on DES-exposed women. Obstet Gynecol 1980; 56:333.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kalstone C. Cervical stenosis in pregnancy: a complication of cryotherapy in diethylstilbestrol-exposed women. Am J Obstet Gynecol 1992; 166:502.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shumsky AG, Stuart GC, Nation J. Carcinoma of the cervix following conservative management of cervical intraepithelial neoplasia. Gynecol Oncol 1994; 53:50.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 3212 Version 29.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20556751" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Surgery for cervical intraepithelial neoplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31734069" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: pilot phase of a randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36525620" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Safety and Acceptability of Three Ablation Treatments for High-Grade Cervical Precancer: Early Data From a Randomized Noninferiority Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12748473" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : A cost-effectiveness analysis of management strategies for cervical intraepithelial neoplasia grades 2 and 3.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8307500" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Who finds cervical laser therapy painful?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6702915" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Treatment of cervical intraepithelial neoplasia with electrocautery: report of 426 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10229253" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Is it cost-effective to use a mucosal or paracervical block to relieve the pain and cramping from cryosurgery? A decision model.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10796771" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Surgery for cervical intraepithelial neoplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32925610" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Occupational Exposure to Human Papillomavirus and Vaccination for Health Care Workers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32925610" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Occupational Exposure to Human Papillomavirus and Vaccination for Health Care Workers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7155483" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Morphometric study of intraepithelial neoplasia of the uterine cervix.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7600723" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Cryotherapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7600723" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Cryotherapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2300350" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Analysis of cryolesions in the uterine cervix: application techniques, extension, and failures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10534084" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : A comparison of flat and shallow conical tips for cervical cryotherapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17897647" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Comparison of depth of necrosis achieved by CO2- and N2O-cryotherapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4696965" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Efficacy of cryosurgical treatment of severe cervical intraepithelial neoplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7600724" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Cold coagulation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33089619" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Thermocoagulation versus cryotherapy for the treatment of cervical precancers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4016036" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : The management of cervical intraepithelial neoplasia by coagulation electrodiathermy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6843923" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Electrocoagulation diathermy for cervical dysplasia and carcinoma in situ: a 15-year survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3484375" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Treatment of cervical intraepithelial neoplasia (CIN) by radical electrocoagulation diathermy: 5 years' experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9794661" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : A randomized clinical trial of cryotherapy, laser vaporization, and loop electrosurgical excision for treatment of squamous intraepithelial lesions of the cervix.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4018658" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Laser or cryotherapy for cervical intraepithelial neoplasia: a randomized study to compare efficacy and side effects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6401855" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Cryotherapy and carbon dioxide laser management of cervical intraepithelial neoplasia: a controlled comparison.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3934610" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Comparison of cryo- and carbon dioxide laser therapy for cervical intraepithelial neoplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11240816" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Pattern of CIN recurrence following laser ablation treatment: long-term follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1853913" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Ten years after cryosurgical treatment of cervical intraepithelial neoplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1998626" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Effective destruction of cervical intraepithelial neoplasia (CIN) 3 at 100 degrees C using the Semm cold coagulator: 14 years experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10225299" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Management of pre-invasive disease of the cervix.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1956010" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Complications of cervical cryotherapy in adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8518248" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Destruction of CIN 1 and 2 with the Semm cold coagulator: 13 years' experience with a see-and-treat policy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2502017" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : A ten-year experience treating cervical intraepithelial neoplasia with the CO2 laser.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7422172" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Cervical stenosis following minor gynecologic procedures on DES-exposed women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1536219" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Cervical stenosis in pregnancy: a complication of cryotherapy in diethylstilbestrol-exposed women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8175022" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Carcinoma of the cervix following conservative management of cervical intraepithelial neoplasia.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
